New recommendations on finasteride and Ixchiq vaccine
Measures minimise risk of suicidal thoughts
EU regulators agree workplan to optimise use of data and AI
Vaccine must not be used in people 65 years and above
Public consultation open until end September 2025
Seizing opportunities in a changing medicines landscape
Find medicine
What's new
FAQs
Latest news
Outcomes of the Committee for Veterinary Medicinal Products (CVMP) meeting
Updated vaccines will help maintain protection against disease as virus continues to evolve
Review of medicines containing finasteride and dutasteride concluded
Suicidal thoughts confirmed as side effect of finasteride tablets; no direct link found for dutasteride
EU regulators agree workplan to optimise use of data and artificial intelligence (AI)
Vaccine must not be used in people 65 years and above while review is underway
Information for you
Patients and carers
Healthcare professionals
Animal health professionals
Pharmaceutical Industry
Media
